Bioatla Inc BCAB

‎$‎0.16510(-1.90%)(1D)

• Delayed prices by NASDAQ • in USD

Invest in Bioatla Inc
Today

Create an eToro account to buy BCAB stock on a secure, user-friendly, multi-asset trading platform.

Bioatla Inc BCAB

Buy BCAB

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

Himax Technologies Inc-ADR

Napco Security Technologies Inc

Alexander & Baldwin Inc

‎$‎20.84

+0.05%

3996.HK

China Energy Engineering Corp Limited

‎$‎1.46

-0.68%

MAX

*Past performance is not an indication of future results

Jump to:

About BCAB >
How to Buy? >
Top Guides >

The Bioatla Inc share price is stable this week.

The Bioatla Inc share price today is ‎$‎0.1651, reflecting a ‎-1.90‎% change over the last 24 hours and ‎0‎% over the past week. The current market capitalization of BCAB is ‎$‎12.5M with an average volume in the last three months of 2.47M. The stock has a P/E ratio of -0.15 and a dividend yield of 0%. With the stock’s beta sitting at 1.74

Why invest in stocks on eToro?

Start with ‎$‎50

Low fees

users worldwide

Across 70+ countries

Get Started

BCAB Key Metrics

Market Cap

‎$‎12.5M

Day’s Range

‎$‎0.1612 - ‎$‎0.1758

52W Range

‎$‎0.1101 - ‎$‎2.5

Average Volume (3M)

2.47M

Price-Earnings Ratio

-0.15

Revenue

‎$‎0

Dividend (Yield)

‎$‎0 (0%)

Prev Close

‎$‎0.1683

EPS

‎$‎-1.15

Beta

1.74

How can I buy Bioatla Inc stocks?

To purchase Bioatla Inc:

Create an eToro account:

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.

Search and purchase:

Search the Bioatla Inc (BCAB) page and place an order to buy Bioatla Inc.

Buy BCAB

Looking for more information? Check out our guide on Academy.

What Is Bioatla Inc?

Bioatla Inc is a clinical-stage biotechnology company focused on the development of conditionally active biologic (CAB) antibody therapeutics for the treatment of various types of cancer. It operates globally, targeting markets with high cancer prevalence and accessible healthcare.

Within the pharmaceutical and biotech sector, Bioatla Inc is creating CAB proteins for targeted therapies, which have advantages when compared to traditional antibodies. It continues to focus on CAB antibody therapeutics, which have potential in cancer treatment.

Learn more about the BCAB share performance on eToro.

CEO

Jay M. Short, PhD

Employees

Founded

2007

San Diego, California, US

Med Tech

NASDAQ

Get Started

Top Guides

Our top picks for the most relevant guides from the eToro Academy

Top Dividend Stocks for 2026

Gear up for 2026 with top dividend stocks. Explore the potential of J&J, Chevron, Coca Cola, Verizon, Caterpillar, McDonald’s with eToro’s expert analysts.

Stock Trading And Investing For Beginners

Learn stock trading basics with our beginner's guide. Discover how to choose stocks, manage risks, and build your first investment portfolio.

AI Stocks Poised for Growth in 2026

Gear up for 2026 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.

Go to the Academy >

Invest in Bioatla Inc
Today

Create an eToro account to buy BCAB stock on a secure, user-friendly, multi-asset trading platform.

Get Started

FAQ

What is the current price of Bioatla Inc stock?

The current price of BCAB is ‎$‎0.1651.

What are analysts’ forecasts for Bioatla Inc?

Analysts offer forecasts for Bioatla Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.

What is the market cap of Bioatla Inc?

The market capitalisation of Bioatla Inc is ‎$‎12.5M

Daily Movers

Explore the biggest stocks movers on the market.